| Name | Title | Contact Details |
|---|
Aptihealth is improving higher acuity behavioral healthcare for underserved populations—one member at a time. The company`s virtual-first model and proprietary screening, assessment, and treatment programs give members fast, convenient access to precise, personalized care. Headquartered in Boston and employing over 150, aptihealth has raised over $65 million in funding from leading international equity firms. The company`s care program and data insights are driving breakthroughs in mental health understanding, treatment, outcomes, and cost reduction.
Horizon Services provides a safe and effective place for individuals to receive addiction treatment and begin their journey toward sustainable, fulfilling recovery. Our Mission is to cultivate or restore a sense of hope, self-awareness and community to people impacted by substance use and mental health challenges by providing effective trauma informed prevention, treatment, and recovery services.
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
Advion BioSciences, Inc. was founded in 1993 based on the novel techniques developed within the Cornell University laboratory of Dr. Jack Henion, a leading researcher in the field of Liquid Chromatography/Mass Spectrometry (LC/MS).
Connolly Strategies and Initiatives is a Annapolis, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.